Back to Search Start Over

Environmental oxygen affects ex vivo growth and proliferation of mesenchymal progenitors by modulating mitogen-activated protein kinase and mammalian target of rapamycin signaling.

Authors :
da Graça Cabreira M
Wang X
Critsinelis A
Setegne M
Lotfi P
Wan YW
Barrios G
Mei Z
Gee AP
Buja LM
Perin E
Source :
Cytotherapy [Cytotherapy] 2022 Dec; Vol. 24 (12), pp. 1201-1210. Date of Electronic Publication: 2022 Sep 13.
Publication Year :
2022

Abstract

Background Aims: Stem and progenitor cells of hematopoietic and mesenchymal lineages reside in the bone marrow under low oxygen (O <subscript>2</subscript> ) saturation. O <subscript>2</subscript> levels used in ex vivo expansion of multipotent mesenchymal stromal cells (MSCs) affect proliferation, metabolism and differentiation.<br />Methods: Using cell-based assays and transcriptome and proteome data, the authors compared MSC cultures simultaneously grown under a conventional 19.95% O <subscript>2</subscript> atmosphere or at 5% O <subscript>2</subscript> .<br />Results: In 5% O <subscript>2</subscript> , MSCs showed better proliferation and higher self-renewal ability, most probably sustained by enhanced signaling activity of mitogen-activated protein kinase and mammalian target of rapamycin pathways. Non-oxidative glycolysis-based energy metabolism supported growth and proliferation in 5% O <subscript>2</subscript> cultures, whereas MSCs grown under 19.95% O <subscript>2</subscript> also utilized oxidative phosphorylation. Cytoprotection mechanisms used by cells under 5% O <subscript> <subscript>2</subscript> </subscript>  differed from 19.95% O <subscript> <subscript>2</subscript> </subscript>   suggesting differences in the triggers of cell stress between these two O <subscript> <subscript>2</subscript> </subscript>   conditions.<br />Conclusions: Based on the potential benefits for the growth and metabolism of MSCs, the authors propose the use of 5% O <subscript>2</subscript> for MSC culture.<br /> (Copyright © 2022 International Society for Cell & Gene Therapy. Published by Elsevier Inc. All rights reserved.)

Details

Language :
English
ISSN :
1477-2566
Volume :
24
Issue :
12
Database :
MEDLINE
Journal :
Cytotherapy
Publication Type :
Academic Journal
Accession number :
36109320
Full Text :
https://doi.org/10.1016/j.jcyt.2022.06.005